Andrew Kambugu

Kambugu was born on 22 February 1973 in Kampala, Uganda. He attended Buganda Road Primary School, King's College Budo for both O & A level and in 1992 he was enrolled at Makerere University, Uganda for a Bachelor of Medicine and surgery and a Masters degree in Medicine specialising in Internal Medicine graduating in 1997 and 2002 respectively.[1] He is a trained fellow in infectious diseases from University of Manitoba.[6][2]

Kambugu did his medical internship at Mulago National hospital in Kampala (1997–98) and has served as a Medical Officer of Uganda Telecom (1998-1999), as a Medical Resident in the Department of Medicine at Makerere University Medical School (October 1998-November 2002),[7] as a physician attending Ward 4B at Mulago Hospital (December 2002 - August 2005) as Head of Preventative Care and Treatment Programme (2005-2012),[7] as Head of Research Programme (May 2012- update) and in May 2013 he was appointed as The Sande-McKinnell Executive Director at Infectious Disease Institute.[6][1] Kambugu is a Honorary Senior lecturer in the Department of Medicine at Makerere University College of Health Sciences.[2] He has presented at Medical conferences inside and outside Uganda such as at Retroviruses and Opportunistic Infections, The International AIDS conference, The South Africa HIV Clinicians Society (2014, 2016), The International Workshop on HIV in Resource Limited Settings(2012, 2014, 2015 $2016).[8] Kambugu serves as a consultant to the World Health Organization on Antiretroviral Therapy since 2010.[9]

He is cited with an H-Index of 39, i10 index of 120 and with 6598 citations in over 120 peer-reviewed journal in scientific publications.[10][11] He is a Council member for African Centers of Excellence in Bioinformatics.[6][12]

Some of his most cited articles are listed below;

• Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis[13]
• Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy[14]
• Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions[15]
• Cost-Effectiveness of Serum Cryptococcal Antigen Screening to Prevent Deaths among HIV-Infected Persons with a CD4+ Cell Count ≤100 Cells/μL Who Start HIV Therapy in Resource-Limited Settings[16]
• Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study[17]
• Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy
• Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome[18]
• Assessment of second-line antiretroviral regimens for HIV therapy in Africa[19]
• Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy[20]
• Tuberculosis immune reconstitution inflammatory syndrome in countries with limited resources[21]
• Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort[22]
• Retention in Care and Patient-Reported Reasons for Undocumented Transfer or Stopping Care Among HIV-Infected Patients on Antiretroviral Therapy in Eastern Africa: Application of a Sampling-Based Approach[23]
• Belief in divine healing can be a barrier to antiretroviral therapy adherence in Uganda[24]

Kambugu is married to Joyce Balagadde-Kambugu and they have two children.[25]

• Website of Infectious Diseases Institute